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Abstract
Background: Acute-onset neurodegenerative diseases in older patients are rare clinical cases, especially when the
degeneration only affects specific regions of the nervous system. Several neurological disorders have been
described in which the degeneration of brain parenchyma originates from and/or primarily affects the brain stem.
Clinical diagnosis in these patients, however, is often complicated due to a poor understanding of these diseases
and their underlying mechanisms.
Case presentation: In this manuscript we report on a 73-year-old female who had experienced a sudden onset of
complex neurological symptoms that progressively worsened over a period of 2 years. Original evaluation had
suggested a MRI-negative stroke as underlying pathogenesis. The combination of patient’s medical history, clinical
examination and exceptional pattern of brain stem degeneration presenting as “kissing swan sign” in MR imaging
was strongly suggestive of acute onset of Alexander’s disease. This leukoencephalopathy is caused by GFAP (glial
fibrilary acidic protein) gene mutations and may present with brain stem atrophy and stroke-like onset of
symptoms in elderly individuals. However, a pathognomonic GFAP gene mutation could not be identified by
Sanger sequencing.
Conclusions: After an extended differential diagnosis and exclusion of other diseases, a definite diagnosis of the
patient’s condition presently remains elusive. However, whole-exome sequencing performed from patient’s blood
revealed 12 potentially disease-causative heterozygous variants, amongst which several have been associated with
neurological disorders in vitro and in vivo – in particular the axon degeneration-related NMNAT2 gene.
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Background
Neurodegenerative diseases can selectively target subpop-
ulations of neurons in the CNS, leading to the progressive
failure of defin22ed brain systems with consecutive
disease-specific clinical features [1]. In various known
neurological disorders, the degeneration of brain paren-
chyma originates from and/or primarily affects the brain
stem, such as in olivopontocerebellar atrophy (OPCA),
progressive supranuclear palsy (PSP), several spinocerebel-
lar ataxia (SCA) types and various entities of leukodystro-
phies [2–4]. Most of these disorders have been directly or
indirectly linked to specific gene mutations.
Even for long-lasting progressive neurodegenerative
diseases, it has been shown that the actual cell death of
neurons occurs rapidly over several hours [5]. Import-
antly, genetic mutations known to provoke specific neu-
rodegenerative disorders often accelerate the very same
molecular cascades that occur in late-onset types of the
same diseases where those mutations cannot be found
(with a classical example being Parkinson’s disease).
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Case presentation
A 73-year-old woman presented with a two-year history of
progressive memory loss, urinary incontinence and walking
difficulties. She had presented to an outside facility two
years prior with acute onset of symptoms including a fall
event. At the time of her initial presentation, she was diag-
nosed and reported as having had a stroke with negative
findings in native CT, CT angiography and CT perfusion,
as well as brain MR imaging (“MRI-negative stroke”) [6].
Clinical examination of the patient at our clinic now re-
vealed a spastic-ataxic gait with positive pyramid signs and
Romberg’s test, scanning speech, disturbed fine motor skills
and dysmetria of all extremities.
Neuropsychological investigation found memory deficits
suggestive of cortical dementia. Cerebrospinal fluid ana-
lysis, however, was normal with regard to both dementia
and tissue destruction markers (Aβ42, total tau and phos-
pho tau). Neither orthostatic nor autonomic dysfunction
could not be detected. The possibility of a paraneoplastic
syndrome was addressed by performing extensive screen-
ing for malignant tumors and known autoantibodies using
imaging and serological evaluation.
Strikingly, brain MR imaging revealed a general atrophy
of brain parenchyma with remarkable emphasis on the
brain stem region (Fig. 1a and b). Here, a manifest gliotic
neurodegeneration in the medulla oblongata with pre-
dominant loss of pyramidal tracts presented as “tadpole”
appearance – a radiological sign exclusively described in
association with Alexander’s disease [7] (Fig. 1a). Even
more prominently, pattern of brain stem degeneration re-
sembled “kissing swans” in coronal sections (Fig. 1c). Im-
portantly, no contrast enhancement could be observed in
the brain stem or any other part of the brain following
Gadolinium administration (Fig. 1d), indicating blood-
brain barrier integrity. Furthermore, a marked atrophy of
the upper cervical spinal cord was detected (Fig. 1e).
Fig. 1 Brain stem degeneration presents in brain MRI. Sagittal (a) and transversal (b) T2-weighted brain MRI indicates gliotic neurodegeneration in the
medulla oblongata with predominant loss of pyramidal tracts. Magnification of inlay (c) uncovers pathologic brain stem formation reminiscent of ‘kissing
swans’. d Transversal T1-weighted sectioning of the brain stem (arrow) after Gadolinium administration. No contrast enhancement is detectable. e Sagittal
T2-weighted cervical spine MRI shows atrophy of the upper cervical spinal cord in addition to medulla oblongata atrophy. f Transversal T2-weighted brain
MRI indicates putative periventricular rim-sign and global brain atrophy. g Brain MRI-angiography reveals normal intracranial vascular status
without indication of stenosis
Schulz et al. Translational Neurodegeneration  (2016) 5:23 Page 2 of 5
DaTscan/IBZM SPECT and FDG-PET results were
neither indicative of idiopathic nor atypical Parkinson’s
disease (not shown).
The combination of patient history and characteristic
brain stem degeneration was strongly reminiscent of
case reports of acute-onset adult Alexander’s disease
(AOAD) [8]. Alexander’s disease is a rare form of leuko-
dystrophy, characterized by white matter degeneration,
mainly caused by gain-of-function mutations of the glial
fibrillary acidic protein (GFAP) in astrocytes [9].
Although most cases were reported to occur sporadically,
autosomal dominant transmissions have been described
[10]. The family history of this patient was devoid of similar
cases, with the important limitation that the patient had
been adopted along with her siblings and has no children
herself. However, personal reports as well as brain MR im-
aging findings of the patient’s sister, niece and grandniece
gave no indication of a comparable disease in the patient’s
family.
In order to genetically examine the suspected diagnosis
of Alexander’s disease, we performed Sanger sequencing
of all coding exons and adjacent intronic regions of the
GFAP gene from the patient’s blood. Strikingly, we could
not identify any mutations in the GFAP gene. Specific gen-
etic testing for the most frequent spinocerebellar ataxia
(SCA) types [11] was also negative.
We therefore performed whole-exome sequencing from
patient’s blood, which provides an unbiased analysis of all
protein-coding sequences in the human genome. Strin-
gent filtering of whole-exome sequencing data for rare
genetic variants (using dbSNP, 1000 genomes project, the
Exome Variant Server and ExAC browser) as well as for
disease-causative variants (using SIFT, Polyphen 2 and
Mutation taster 2) resulted in a list of 12 potentially
disease-causative heterozygous variants (Table 1).
The most notable of these candidate genes was
NMNAT2, which encodes for one isoform of the nico-
tinamide mononucleotide adenylyltransferases. Its neu-
roprotective role in numerous preclinical models of
neurodegeneration is well established. Experimental de-
letion of NMNAT2 function increases the vulnerability
of CNS neurons and accelerates Wallerian degeneration
[12]. Furthermore, NMNAT2 transcript levels have been
shown to negatively correlate with neurodegeneration
in a large study of 541 human individuals [13]. Import-
antly, deletion of a single NMNAT2 allele, analogous to
the heterozygous variant found in the presented
patient, was sufficient to induce neurite degeneration in
primary neuronal cultures [14].
Another candidate gene, STOX1 has been associated
with phosphorylation of tau proteins in late-onset
Alzheimer’s disease [15]. KAT5, in addition, acts as a
nuclear hormone receptor coactivator and has been
linked to spinocerebellar ataxia type 1 [16].
Discussion
Acute onset of chronic neurodegenerative diseases such
as dementia [17] or movement disorders [18] in elderly
individuals can occur as a result of various pathological
conditions. However, the mechanisms determining an
acute disease course as opposed to a slowly-progressive
one for a specific disease are incompletely understood.
For these and other reasons, both the definite diagnosis
and the underlying cause of the presented patient’s con-
dition are yet unknown. The diagnosis of adult-onset
Alexander’s disease (AOAD) as a rare leukoencephalopa-
thy disorder predominantly affecting the brain stem and
having stroke-like onset of symptoms [8] has to be ex-
cluded in this patient’s case, due to the apparent absence
of a detectable GFAP gene mutation; nevertheless, the
unique combination of clinical presentation, patient his-
tory and severe degeneration of the medulla oblongata
are consistent with other reports on the disease.
It therefore needs to be resolved in future studies
whether Alexander’s disease can be caused by mutations
in genes other than GFAP, or whether mutations in
other genes can lead to comparable but independent dis-
ease entities. In fact, phenotypically comparable presen-
tations of adult onset ataxia, dementia, and typical MRI
findings (tadpole sign) have been described in GFAP
mutation-negative patients [19].
Remarkably, the original diagnosis in this case (2 years
prior to the current examination) was MR-negative stroke,
thereby addressing the sudden onset of symptoms. Yet, in
the current follow-up evaluation, no vascular pathologies
(Fig. 1f and g) or cardiovascular risk factors (diabetes mel-
litus, cardiac arrhythmia, smoking, hyperlipidemia) except
for mild hypertension could be determined. Furthermore,
several of the initial symptoms (spasticity and memory
loss in particular) were reported to be steadily progressive
by the patient.
Other possible differential diagnoses as underlying cause
for the patient’s condition (multiple system atrophy,
progressive supranuclear palsy, spinocerebellar ataxia or
paraneoplastic/immunological syndrome etc.) appear
unlikely at this time, based on the existing information.
Conclusions
Despite an extended differential diagnosis and exclusion
of other possible diseases, a definite diagnosis of the pre-
sented case remains elusive. The diagnosis of adult-onset
Alexander’s disease predominantly affecting the brain
stem with stroke-like onset of symptoms has to be ex-
cluded, because of the apparent absence of a detectable
GFAP gene mutation. Yet, stringent filtering of whole-
exome sequencing data reveals 12 potentially disease-
causative heterozygous variants, which may impact the
patient’s condition. Additional cases or disease-mimicking
animal models with targeted gene knockout or over-
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expression of candidate genes will be necessary to clarify a
disease-causative potential of the candidates shown in
Table 1.
However, the identification of several genes with experi-
mentally proven connection to neurodegenerative diseases,
in particular the axon degeneration-related gene NMNAT2,
as well as the uniqueness of this case suggest a genetic
cause for the patient’s debilitating and progressive
condition.
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